Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on: January 22,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on:January 22,2024

How post-feeding breasts bounce back from the brink of death to kick-start milk production

byUniversity of SheffieldDelayed alveolar regression in Rac1−/− glands in involution. (A-D) Carmine staining of whole-mounted mammary glands of WT (A, C) and Rac1−/− (B, D) mice at postlactation

Updated on: January 02,2024

How post-feeding breasts bounce back from the brink of death to kick-start milk production

byUniversity of SheffieldDelayed alveolar regression in Rac1−/− glands in involution. (A-D) Carmine staining of whole-mounted mammary glands of WT (A, C) and Rac1−/− (B, D) mice at postlactation

Updated on:January 02,2024

Study confirms new prognostic markers for triple negative breast cancer

by SWOGCredit: CC0 Public DomainPhysicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery tre

Updated on: March 08,2024

Study confirms new prognostic markers for triple negative breast cancer

by SWOGCredit: CC0 Public DomainPhysicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery tre

Updated on:March 08,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on: April 30,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on:April 30,2024

Interpreting and Commenting on the Role of Oct4 in M2 Macrophage Polarization and Tumor Progression in Lung Cancer

Updated on: October 01,2024

Interpreting and Commenting on the Role of Oct4 in M2 Macrophage Polarization and Tumor Progression in Lung Cancer

Updated on:October 01,2024

Spontaneous humor relieves stress in cancer patients

by Lancaster UniversityDrawings taken from Lancaster University’s ‘Metaphor Menu’, a collection of examples of different ways in which people described their experiences with cancer . Credit: Lan

Updated on: April 01,2024

Spontaneous humor relieves stress in cancer patients

by Lancaster UniversityDrawings taken from Lancaster University’s ‘Metaphor Menu’, a collection of examples of different ways in which people described their experiences with cancer . Credit: Lan

Updated on:April 01,2024

Study indicates who faces highest risk of HPV infection and anal cancer

by Andrew Smith,Rutgers UniversityElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainPrevious sexually transmitted infectio

Updated on: January 23,2024

Study indicates who faces highest risk of HPV infection and anal cancer

by Andrew Smith,Rutgers UniversityElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainPrevious sexually transmitted infectio

Updated on:January 23,2024

Active surveillance feasible for low-risk thyroid cancer

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 inJAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Cente

Updated on: January 21,2024

Active surveillance feasible for low-risk thyroid cancer

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 inJAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Cente

Updated on:January 21,2024

New insights into aggressive breast cancer and potential treatment options

by Marianne Lie Becker,University of Southern DenmarkThe findings made in the recent research projects. Credit: Professor Vijay Tiwari, University of Southern DenmarkTriple-negative breast cance

Updated on: April 06,2024

New insights into aggressive breast cancer and potential treatment options

by Marianne Lie Becker,University of Southern DenmarkThe findings made in the recent research projects. Credit: Professor Vijay Tiwari, University of Southern DenmarkTriple-negative breast cance

Updated on:April 06,2024

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on: March 30,2024

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on:March 30,2024

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

Updated on: February 24,2024

T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainSecond-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with t

Updated on:February 24,2024

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on: May 06,2024

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on:May 06,2024